QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：西安交通大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 LRIG1 promotes the apoptosis of pituitary tumor cells induced by cisplatin]. 期刊论文 Chinese journal of cellular and molecular immunology, 2018, 卷号: 34, 页码: 9-15 作者:  Zhou Linyu;  Bao Chunyan;  Hu Xiao;  Dai Yongqing;  Bao Zhijun 收藏  |  浏览/下载：6/0  |  提交时间：2019/11/19 Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study. 期刊论文 Clinical and experimental rheumatology, 2018 作者:  Bi Liqi;  Li Yuhui;  He Lan;  Xu Huji;  Jiang Zhenyu 收藏  |  浏览/下载：21/0  |  提交时间：2019/11/19 Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma. 期刊论文 Journal of cellular biochemistry, 2018 作者:  Bao Zhijun;  Chen Lihua;  Guo Shiwen 收藏  |  浏览/下载：12/0  |  提交时间：2019/11/26 solute carrier 34 A2  glioma  cell proliferation  metastasis  chemosensitivity  EGFR/PI3K/AKT signaling pathway   Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial 期刊论文 ARTHRITIS & RHEUMATOLOGY, 2018, 卷号: 70 作者:  Fu, Qiong;  Lu, Liangjing;  Xu, Jianhua;  Dai, Lie;  Li Zhijun 收藏  |  浏览/下载：2/0  |  提交时间：2019/11/26 Different response to neoadjuvant chemotherapy for different molecular subtypes in patients with locally advanced breast cancer 期刊论文 Chinese-German Journal of Clinical Oncology, 2013, 卷号: 12, 期号: [db:dc_citation_issue] 作者:  Kang, Huafeng;  Dai, Zhijun;  Ma, Xiaobin;  Bao, Xing;  Lin, Shuai 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/10 breast cancer  molecular subtype  neoadjuvant chemotherapy  response rate